Skip to main content
2025 DC/CSEM Professional Conference Main banner
On-Demand

Plenary Session

PS2 - Practical Approaches to Sick-Day and Peri-operative Management for people living with diabetes

Thursday, November 27, 2025
16:00 - 17:00 Toronto
Location: Constitution Hall

    Speaker(s)

  • Kandus M. Wainman, NP/CNS,BScN,CDE (she/her/hers)

    Nurse Practitioner
    St Josephs Healthcare London
    London, Ontario, Canada

    Disclosure(s): Abbott Diabetes Care: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medtronic Diabetes of Canada: Independent Contractor (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Speaker/Honoraria (Terminated, November 1, 2024); Roche Diabetes Care: Independent Contractor (Terminated, January 1, 2016); Sanofi Canada: Independent Contractor (Terminated, January 1, 2018)

  • Jill Trinacty, MD, FRCPC, ABOM (she/her/hers)

    Endocrinologist
    LMC Ottawa
    Nepean, Ontario, Canada

    Disclosure(s): Abbott: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Advisory Board (Ongoing); Catalytic Health: Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); CCRN: Speaker/Honoraria (Ongoing); CME Away: Speaker/Honoraria (Ongoing); CPD Network: Speaker/Honoraria (Ongoing); Dexcom: Advisory Board (Ongoing), Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeautics: Advisory Board (Ongoing); Humber River Health: Speaker/Honoraria (Ongoing); Lilly: Advisory Board (Ongoing), Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Advisory Board (Ongoing); Novo Nordisk: Advisory Board (Ongoing), Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); Tandem: Advisory Board (Ongoing)

  • Sharon Peacock, MD, FRCPC (she/her/hers)

    Staff Anesthesiologist
    Mount Sinai Hospital/Sinai Health
    Department of Anesthesia and Pain Medicine, University of Toronto
    Toronto, Ontario, Canada

    Disclosure(s): I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

    • Moderator(s)

  • Jeremy Gilbert, Dr

    Endocrinologist
    Sunnybrook Health Sciences Centre
    University of Toronto
    Toronto, Ontario, Canada

    Disclosure(s): Abbott Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Speaker/Honoraria (Ongoing); Bayer Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Speaker/Honoraria (Ongoing); Novo Nordisk Canada Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Disclosure(s):
Kandus M. Wainman, NP/CNS,BScN,CDE: Abbott Diabetes Care: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medtronic Diabetes of Canada: Independent Contractor (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Speaker/Honoraria (Terminated, November 1, 2024); Roche Diabetes Care: Independent Contractor (Terminated, January 1, 2016); Sanofi Canada: Independent Contractor (Terminated, January 1, 2018)
Jill Trinacty, MD, FRCPC, ABOM: Abbott: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Advisory Board (Ongoing); Catalytic Health: Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); CCRN: Speaker/Honoraria (Ongoing); CME Away: Speaker/Honoraria (Ongoing); CPD Network: Speaker/Honoraria (Ongoing); Dexcom: Advisory Board (Ongoing), Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeautics: Advisory Board (Ongoing); Humber River Health: Speaker/Honoraria (Ongoing); Lilly: Advisory Board (Ongoing), Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Advisory Board (Ongoing); Novo Nordisk: Advisory Board (Ongoing), Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); Tandem: Advisory Board (Ongoing)
Sharon Peacock: I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose
Jeremy Gilbert, MD, FRCPC: Abbott Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Speaker/Honoraria (Ongoing); Bayer Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Speaker/Honoraria (Ongoing); Novo Nordisk Canada Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)
Learning Objectives: This session will do the following:
1. Review the pros and cons of SADMANS with a practical approach to sick day management.
2. Describe appropriate peri-operative management of insulin, SGLT-2i and GLP-1a.
3. Apply the advice around perioperative management of diabetes medications from the endocrinology and anesthesiology perspectives.